Asahi Kasei Pharma Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The companys portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescription drugs are used for the treatment of osteoporosis pain, disseminated intravascular coagulation, bone loss, dysuria accompanying benign prostatic hyperplasia, nocturia, proteinuria in nephrotic syndrome and lupus nephritis, and difficulty in urination. Asahi Kasei Pharma offers assay kits that determine glycemic control and detect prediabetes. The companys pipeline includes candidates for acute exacerbation of idiopathic pulmonary fibrosis; chemotherapy-induced peripheral neuropathy; osteoporosis with high risk of fracture; Lupus nephritis and nephrotic syndrome; and for severe sepsis with coagulopathy. It manufactures pharmaceuticals and diagnostic kits at its manufacturing plants in Shizuoka, and Nagoya in Japan. Asahi Kasei Pharma is headquartered in Tokyo, Japan.

Asahi Kasei Pharma Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
XERIS Pharma Enters into Agreement with Asahi Kasei Pharma 10
DeNA and DeNA Life Science Enter into Research Partnership with Asahi Kasei Pharma and Shionogi 11
Evotec Enters into Agreement with Asahi Kasei Pharma 12
Orion Enters into Agreement with Asahi Kasei Pharma 13
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 14
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 15
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 16
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 17
Licensing Agreements 18
Asahi Kasei Pharma Enters into Licensing Agreement with Sanofi 18
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 19
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 20
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 21
Asahi Kasei Pharma Corp - Key Competitors 22
Asahi Kasei Pharma Corp - Key Employees 23
Asahi Kasei Pharma Corp - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Key Facts 2
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Pharma Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
XERIS Pharma Enters into Agreement with Asahi Kasei Pharma 10
DeNA and DeNA Life Science Enter into Research Partnership with Asahi Kasei Pharma and Shionogi 11
Evotec Enters into Agreement with Asahi Kasei Pharma 12
Orion Enters into Agreement with Asahi Kasei Pharma 13
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 14
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 15
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 16
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 17
Asahi Kasei Pharma Enters into Licensing Agreement with Sanofi 18
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 19
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 20
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 21
Asahi Kasei Pharma Corp, Key Competitors 22
Asahi Kasei Pharma Corp, Key Employees 23
Asahi Kasei Pharma Corp, Other Locations 24
Asahi Kasei Pharma Corp, Subsidiaries 24

List Of Figures


Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Asahi Kasei Pharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Hemodialysis Bloodline System Market Global Review and Outlook by 12 Companies (B. Braun, Allmed, Nipro, Asahi Kasei, Fresenius etc.), by Application (Hospital Hemodialysis, Home Hemodialysis)

Hemodialysis Bloodline System report is in-depth investigation for Global market. Hemodialysis Bloodline System market was valued at USD XX million Global in 2018 and is forecasted to reach USD XXX

USD 3000 View Report

Hemodialysis Bloodline System Market Global Review and Outlook by 12 Companies (B. Braun, Allmed, Nipro, Asahi Kasei, Fresenius etc.), by Application (Hospital Hemodialysis, Home Hemodialysis)

Hemodialysis Bloodline System report is in-depth investigation for Global market. Hemodialysis Bloodline System market was valued at USD XX million Global in 2018 and is forecasted to reach USD XXX

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available